Filing Details

Accession Number:
0001626199-21-000112
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-09-21 17:12:50
Reporting Period:
2021-09-17
Accepted Time:
2021-09-21 17:12:50
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1626199 Alpine Immune Sciences Inc. ALPN () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1487815 Xiangmin Cui C/O Alpine Immune Sciences, Inc.
188 East Blaine Street, Suite 200
Seattle WA 98102
Yes No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2021-09-17 1,542,553 $9.40 4,708,288 No 4 P Indirect See Footnote
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect See Footnote
Footnotes
  1. The reportable securities are owned directly by Decheng Capital China Life Sciences USD Fund III, L.P. (the "Fund"). The Reporting Person is the manager of the general partner of the Fund. The Reporting Person disclaims beneficial ownership of these securities, except to the extent of his pecuniary interests therein.